Figure 1 | Scientific Reports

Figure 1

From: VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment

Figure 1

Probe associated material differences. (A) Patients’ VEGF-165b serum levels are plotted in a box plot diagram over the course of treatment: initiation of chemotherapy (blood sample 1 = BS 1), after completion of chemotherapy (blood sample 2 = BS 2) and two years after completion of therapy (blood sample 3 = BS 3) and for healthy controls (control). (B) Accordingly, VEGF-165b plasma values are displayed.

Back to article page